ITMCTR2100004677尚未招募4 期
A prospective, randomized, controlled, single blind clinical study of Shenqigui oral liquid for improving bone marrow suppression in patients with small cell lung cancer of Qi and yin defi
Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •(1) Clinically, it is clearly diagnosed as a wide range of small cell lung cancer;
- •(2) Chinese medicine is divided into gas and yin;
- •(3) Popular semen of small cell lung cancer;
- •(4) Compliance with the joint chemotherapy standard, parallel cycle treatment;
- •(5) Age 18-75 years old, male or female;
- •(6) Agree to receive traditional Chinese medicine treatment;
- •(7) Informed consent and signed an informed consent book.
排除标准
- •(1) Expected survival time <3 months;
- •(2) Merge hematopoietic dysfunction;
- •(3) Women within pregnancy or lactation;
- •(4) Severe mental illness;
- •(5) Accompanied by severe heart and brain, liver, kidney and other diseases;
- •(6) Unable to accept oral drug therapy;
- •(7) Kidney gas returning oral liquid and its ingredient allergic;
- •(8) Blood transfusion therapy;
- •(9) Simultaneous radiotherapy.
研究者
相似试验
已完成
不适用
A clinical trial to find out whether nasal administration of Ketamine is as good as intravenous route for sedation prior to minor procedures in children presenting to the Emergency department.CTRI/2014/08/004919one40
已完成
3 期
Clinical study to evaluate efficacy and safety ofDydrogesterone 20 mg Tablets Compared toDydrogesterone 10 mg tablet in the Management Of EndometriosisCTRI/2024/04/065082Ms Abbott India Limited230
已完成
不适用
A prospective, randomized, cross-over, single-blind, placebo-controlled study to assess the pharmacodynamic effects, pharmacokinetics and safety and tolerability of one dose of 30 mg ulipristal acetate (UPA) followed by the administration of 20 days of 75 µg desogestrel (DSG)Contraceptioncontraceptionfertility controlNL-OMON39702HRA Pharma35
已完成
3 期
Study of the efficacy and safety of Epalrestat to Pregabalin in patients suffering from painful diabetic peripheral neuropathy.CTRI/2013/05/003646Investigator Initiated study240
已完成
3 期
Effectiveness of Epalrestat in treatment of diabetic patients suffering due to damage of peripheral nerves.CTRI/2015/02/005538Primary Investigator100